Shouyao Holdings (Beijing) Co. LTD

Quick facts

Phase 3 pipeline

• Crizotinib Capsules · Oncology
  Crizotinib is a tyrosine kinase inhibitor that blocks ALK (anaplastic lymphoma kinase) and ROS1 signaling to inhibit cancer cell growth.
• SY-3505 Capsules · Diabetes
  SY-3505 Capsules is a small molecule that targets the SGLT2 receptor.
• SY-5007 · Diabetes
  SY-5007 is a small molecule that targets the SGLT2 receptor.

Phase 2 pipeline

• SY-3505

Phase 1 pipeline

• [14C] SY-5007
• CT-707
• SY-4798
• SY-4835
• SY-5933
• SY-9453

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shouyao Holdings (Beijing) Co. LTD portfolio CI brief
• Shouyao Holdings (Beijing) Co. LTD pipeline updates RSS